PipelinePharma Logo

Generics 1

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Nilotinib manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Malta

Clear all

1 products found

nilotinib

Oral solution 50 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #21467

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.

Manufacturer usually replies in 23 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the drug Nilotinib?

Nilotinib is a selective tyrosine kinase inhibitor. Nilotinib is medication to treat blood cancer and, more precisely, patients with Philadelphia chromosome-positive chronic myelogenous leukemia. The nilotinib drug is usually used when other treatments have failed; it is to overcome Imatinib when patients are resistant to this drug. Nilotinib is a second-generation tyrosine kinase inhibitor. Due to its rare use, Nilotinib is considered an “orphan medicine.”
Nilotinib medication was approved in 2007 by the FDA and in 2009 by the EU EMA. Nilotinib is on the list of the World Health Organization’s essential medicines.

Nilotinib wholesalers and manufacturers:

Novartis manufactures Nilotinib under the name Tasigna. Novartis is also the marketing authorization holder.
Nilotinib suppliers market it in the form of oral capsules. Nilotinib can be found in capsules of 50 mg, 100 mg, and 200 mg.

Nilotinib for sales:

The retail prices of Nilotinib depend on the dosage of the capsule. In the US, for a 50 mg capsule, Nilotinib costs around $ 137 per unit, it equals to $ 16,470 for 120 capsules. For 150 mg and 200 mg, one Nilotinib capsule costs $ 137, and for 28 capsules, it costs $ 3,850.
Nilotinib is mostly available from the European Union, India, and the United States on the Pipelinepharma B2B marketplace. If you are looking for Nilotinib manufacturers, our online platform will help Nilotinib distributors to connect globally with qualified manufacturers that have been verified through quality control procedures. On Pipelinepharma website, you can find a list of many pharmaceutical products, including Nilotinib. Thanks to our very intuitive website, you can easily place an order for Nilotinib and be in relation with Nilotinib manufacturers.

How to use Nilotinib drug?

Depending on the phase the patient is in, the Nilotinib dosage will be adjusted. For a newly diagnosed patient, the usual dose for an adult is 300 mg taken twice a day. For a resistant patient, the prescription for an adult is 400 mg taken twice a day. In both cases, Nilotinib drugs must be taken orally within 12 hours in between the two doses. It is better to take Nilotinib medication on an empty stomach; it means no food 2 hours before taking the drug and 1 hour after taking it.
Nilotinib medication can have some side effects; the most common ones are nausea, rash, headache, and fatigue. Patients should not take Nilotinib if they are allergic if they have low blood levels of potassium or magnesium or a heart rhythm disorder called long QT syndrome.
It must be stored at room temperature, away from heat, moisture, and direct light.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.